Mepyramine hydrochloride (Synonyms: Pyrilamine hydrochloride)

Cat. No.: HY-118807A: Ficha de datos Instrucciones de manejo
FAQs
Technical Support

Mepyramine hydrochloride (Pyrilamine hydrochloride) is a selective histamine H1 receptor antagonist and KCNQ channel inhibitor, with an IC₅₀ of 12.5 μM against KCNQ2/Q3. Mepyramine hydrochloride shows no activity against allergic asthma in mice when used alone, but modulates the effect of JNJ 7777120 (HY-13508) on allergic asthma in mice; it inhibits the development of morphine physical dependence and increases histamine levels in mouse brains. Mepyramine hydrochloride can be used in studies related to seizures, convulsions, allergic asthma and morphine physical dependence.

Para uso exclusivo en investigación. No vendemos a pacientes.

Mepyramine hydrochloride Estructura química

No. CAS : 6036-95-9

Tamaño		Stock
MOQ		Minimum order quantity
50 mg		Obtener un presupuesto
100 mg		Obtener un presupuesto
250 mg		Obtener un presupuesto
Other size		Obtener un presupuesto

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Mepyramine hydrochloride:

Mepyramine maleate

Other Forms of Mepyramine hydrochloride:

Mepyramine maleate In-stock

2 Publications Citing Use of MCE Mepyramine hydrochloride

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas Histamine Receptor:

Ver todas las isoformas

H₁ Receptor H₂ Receptor H₃ Receptor H₄ Receptor Histamine Receptor

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn

IC₅₀ & Target^[1]

H₁ Receptor

KCNQ2/Q3

12.5 μM (IC₅₀)

In Vitro

Hydrochloride of mepyramine (100 μM) potently and reversibly inhibits heterologously expressed KCNQ2/Q3 channels in HEK293 cells, with an IC₅₀ of 12.5 μM, and alters channel gating kinetics and voltage-dependent activation in a voltage-dependent manner^[1].
Mepyramine hydrochloride inhibits homologous KCNQ1, KCNQ2, KCNQ3, KCNQ4 channels and heterologous KCNQ3/Q5 channels in HEK293 cells, with differential inhibitory potency; it exhibits the strongest activity against KCNQ3/Q5 (IC₅₀ = 4.2 μM) and KCNQ3 (IC₅₀ = 9.1 μM)^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics

Species	Dose	Route	T_1/2 (Distribution)	T_1/2β	AUC_0-inf	V_dss	MRT	Bioavailability	T_max	C_max
Horse^[3]	0.52-0.66 mg/kg	i.v.	0.308 h	1.67 h	297 ng·h/mL	1901 L	1.76 h	/	/	/
Horse^[3]	0.52-0.66 mg/kg	p.o.	/	/	54.6 ng·h/mL	/	1.48 h	18.4 %	0.44 h	36.6 ng/mL

In Vivo

Pyrilamine (20 mg/kg; s.c.) alone has minimal independent effect on murine allergic asthma parameters, but exerts phase-dependent modulation of JNJ 7777120 (HY-13508) efficacy, inhibiting beneficial effects during provocation and enhancing beneficial effects during sensitization^[2].
Pyrilamine (mepyramine) (50 mg/kg; i.p.; single dose) administered at the start of morphine dependence induction in WHT/Ht mice inhibits the development of morphine physical dependence (requiring 34.5-fold higher naloxone dose to precipitate 50% withdrawal jumping) without affecting morphine tolerance, and increases brain histamine levels by 25-37%^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Balb/c (female, 8 weeks old, acclimatized for ≥2 weeks prior to experiments)^[2]
Dosage:	20 mg/kg
Administration:	s.c.; 30 minutes before each ovalbumin exposure (provocation phase); 30 minutes before and 2 hours after each ovalbumin injection (sensitization phase)
Result:	Showed no significant reduction in BAL-fluid eosinophil numbers, no effect on lung tissue inflammatory infiltration scores, and no change in serum anti-OVA IgE, IL-13, or IL-5 concentrations relative to DMSO controls when administered during provocation. Showed no significant reduction in BAL-fluid eosinophil numbers, reduced lung tissue inflammatory infiltration scores relative to DMSO controls, and no change in serum anti-OVA IgE, IL-13, or IL-5 concentrations relative to DMSO controls when administered during sensitization. Inhibited JNJ 7777120-induced reductions in BAL-fluid eosinophil numbers and serum anti-OVA IgE concentrations when co-administered during provocation. Enhanced JNJ 7777120-induced reductions in BAL-fluid eosinophil numbers and lung inflammatory infiltration scores, and significantly reduced serum IL-13 and IL-5 concentrations relative to DMSO controls when co-administered during sensitization.

Animal Model:	WHT/Ht (either sex, 25 to 40 g, morphine dependence induced via subcutaneous implantation of 7 mg morphine sulphate-impregnated molecular sieve pellets)^[4]
Dosage:	50 mg/kg
Administration:	i.p.; single dose
Result:	Increased brain histamine levels 24 hours post-treatment: Non-tolerant mepyramine-treated mice had 25% higher brain histamine than non-tolerant controls; tolerant mepyramine-treated mice had 37% higher brain histamine than tolerant controls. Brain histamine was 16% higher in tolerant mepyramine-treated mice than non-tolerant mepyramine-treated mice. All increases were statistically significant.

Peso molecular

321.84

Fòrmula

C₁₇H₂₄ClN₃O

No. CAS

6036-95-9

SMILES

COC(C=C1)=CC=C1CN(CCN(C)C)C2=NC=CC=C2.Cl

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureza y Documentación

Instrucciones de manejo (2659 KB)

Referencias

[1]. Liu B, et al. Antihistamine mepyramine directly inhibits KCNQ/M channel and depolarizes rat superior cervical ganglion neurons. Neuropharmacology. 2008;54(4):629-639. [Content Brief]

[2]. Beermann S, et al. Opposite effects of mepyramine on JNJ 7777120-induced amelioration of experimentally induced asthma in mice in sensitization and provocation. PLoS One. 2012;7(1):e30285. [Content Brief]

[3]. Dirikolu L, et al. Pyrilamine in the horse: detection and pharmacokinetics of pyrilamine and its major urinary metabolite O-desmethylpyrilamine. J Vet Pharmacol Ther. 2009;32(1):66-78. [Content Brief]

[4]. Hui KS, et al.The effect of mepyramine on the development of morphine tolerance and physical dependence in mice. Life Sci. 1975 Sep 15;17(6):891-9. [Content Brief]

Mepyramine hydrochloride Related Classifications

Neurological Disease Inflammation/Immunology

Calculadora de molaridad
Calculadora de dilución

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass		Concentration		Volume		Molecular Weight *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)	×	Volume _(start)	=	Concentration _(final)	×	Volume _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Mepyramine6036-95-9PyrilamineHistamine ReceptorPotassium ChannelKcsAallergic asthmaseizuresWHT/Ht miceblood-brain barriermorphine physical dependenceconvulsionsKCNQ channelurticariaHEK293 cellshistamine H1 receptorInhibitorinhibitorinhibit

Productos vistos recientemente:

Nombre del producto

Requested Quantity *

Nombre del solicitante *

Saludo

Direcciòn del E-mail *

Número de teléfono *

Department

Nombre de la Organizaciòn *

City

Provincia

Country or Region *

Observaciones

Nombre del producto

Lot #

Nombre del solicitante *

Direcciòn del E-mail *

Número de teléfono

Department *